Prevention of contrast nephropathy with allopurinol. A randomized controlled trial

MLA

Sezgin, At, et al. Prevention of Contrast Nephropathy with Allopurinol. A Randomized Controlled Trial. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4800a68c20e52798bd4c794046fa5971&authtype=sso&custid=ns315887. Accessed 25 Jan. 2025.

APA

Sezgin, A., Katircibasi, T., Zumrutdal, A., Tekin, G., Kocum, T., Tekin, A., fatma yigit, Erol, T., Ermis, N., Sezgin, N., Demircan, S., & Muderrisoglu, H. (n.d.). Prevention of contrast nephropathy with allopurinol. A randomized controlled trial.

Chicago

Sezgin, At, T. Katircibasi, A. Zumrutdal, G. Tekin, T. Kocum, A. Tekin, fatma yigit, et al. 2025. “Prevention of Contrast Nephropathy with Allopurinol. A Randomized Controlled Trial.” Accessed January 25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4800a68c20e52798bd4c794046fa5971&authtype=sso&custid=ns315887.